Citigroup Inc Syros Pharmaceuticals, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.69 - $1.21 $1,108 - $1,943	-1,606 Reduced 44.41%	2,010 $2,000
Q1 2022 May 12, 2022	SELL	$1.02 - $3.8 $13,168 - $49,058	-12,910 Reduced 78.12%	3,616 $4,000
Q4 2021 Feb 10, 2022	BUY	$3.26 - $4.66 $22,246 - $31,799	6,824 Added 70.34%	16,526 $54,000
Q3 2021 Nov 10, 2021	BUY	$4.08 - $5.66 $39,584 - $54,913	9,702 New	9,702 $43,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.